Consolidated Balance Sheets - USD ($)	Jun. 30, 2018	Jun. 30, 2017
Current assets:
Cash and cash equivalents	$ 22,013	$ 72,932
Prepaid expenses	7,474	6,426
Deposits and other receivables	1,000	1,980
Total current assets	30,487	81,338
Property and equipment, net (Note 3)	1,448	3,192
Total assets	31,935	84,530
Current liabilities:
Accounts payable and accrued expenses	719,633	865,841
Deferred compensation (Note 5)	421,641	2,107,262
Convertible notes payable - affiliates (Note 7)		88,927
Loan payable and accrued interest (Note 6)	9,028,983	8,796,322
Total current liabilities	10,201,657	11,887,752
Convertible notes payable - affiliates (Note 7)	3,525,216	3,316,060
Total liabilities	13,726,873	15,203,812
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 25,939,892 and 24,748,213 shares issued, respectively; 25,235,583 and 24,043,904 shares outstanding, respectively
Additional paid-in capital	108,117,330	103,540,352
Subscription receivable - affiliates (Note 8)	(174,650)	(40,000)
Accumulated deficit	(121,691,956)	(118,676,966)
Total Bion's stockholders’ deficit	(13,749,276)	(15,176,614)
Noncontrolling interest	54,338	57,332
Total deficit	(13,694,938)	(15,119,282)
Total liabilities and deficit	31,935	84,530
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $34,000 and $32,000, respectively (Note 8)	31,400	29,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock